Back to Trades
Holloway Michael Andrew
DirectorCIK 0002076371
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Holloway Michael Andrew, Director, has filed 4 SEC reports (2025–2026), all concentrated in LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT), totaling $179.5K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jul 2 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Holloway Michael Andrew | Director | Grant | $0 |
| Apr 17 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Holloway Michael Andrew | Director | Grant | $89.8K |
| Aug 18 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Holloway Michael Andrew | Director | Award | $89.8K |
| Jul 21 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Holloway Michael Andrew | Director | Other | $0 |
4 filings